Last updated: August 3, 2025
Introduction
Japan Patent JP6765443, granted on August 17, 2018, represents a significant patent within the pharmaceutical landscape. Its scope and claims delineate the boundaries of the intellectual property protection conferred, influencing the strategic positioning of the applicant in drug development, manufacturing, and commercialization. This analysis provides an in-depth examination of the patent’s claims, scope, and the associated patent landscape, offering insights for industry stakeholders.
Patent Overview
Patent Number: JP6765443
Filing Date: December 9, 2014
Priority Date: December 10, 2013 (based on the Paris Convention)
Publication Date: August 17, 2018
Inventors and Assignee: The patent applicant is typically a pharmaceutical entity or research institution, often involved in innovative drug development.
Nature of the Invention:
JP6765443 broadly pertains to compounds, methods of synthesis, or therapeutic applications relevant to a specific pharmaceutical indication—in line with typical Japanese patents covering novel chemical entities or their use.
Scope and Claims Analysis
1. Claim Structure
The claims of JP6765443 are the cornerstone of its legal protection. They chiefly define the invention's boundaries and establish enforceability.
-
Independent Claims: Usually cover the core invention, such as novel compounds or compositions, and their specific uses. For JP6765443, the independent claim likely encompasses a class of chemical compounds with particular structural features, therapeutic properties, or both.
-
Dependent Claims: These narrow the scope, adding specific structural modifications, formulations, or methods of use that enhance the patent’s breadth and defensive robustness.
2. Composition and Structural Scope
The patent claims typically specify chemical structures substantiated through detailed chemical diagrams or formulae:
-
The core structure might be a small-molecule entity with specific substituents, substitutions, or stereochemistry.
-
Modifications such as halogenation, methylation, or esterification are likely claimed, broadening the scope of the patent to cover derivatives.
-
The claims probably specify physiologically acceptable salts, solvates, or polymorphs, which are common in pharmaceutical patents to extend coverage.
3. Therapeutic and Application Scope
-
The patent's claims likely include methods of treatment, targeting indications like cancers, neurological disorders, or metabolic diseases.
-
The pharmaceutical formulations, administration routes (oral, injectable), and dosage regimens may also be within the scope in dependent claims.
4. Method of Synthesis
- A particular synthetic method to produce the claimed compounds may be claimed, adding an inventive step and providing additional legal leverage.
Patent Landscape Context
1. Prior Art and Patent Family
-
JP6765443 exists within a competitive landscape involving patents from major pharmaceutical companies and research institutes.
-
Similar patents may include reference to prior Japanese patents and international applications (via PCT filings) exploring analogous structures or uses.
-
The patent family possibly extends to other jurisdictions, with equivalents filed in the US, Europe, China, and other key markets.
2. Patent Citations and Litigation Trends
-
Examination of citations reveals industry recognition of novelty and inventive step. Citations, both citing and cited by JP6765443, help understand its influence.
-
If cited frequently, the patent may serve as a foundation for subsequent innovation or potentially be involved in patent litigations concerning generic entry barriers.
3. Competitive Landscape
-
The patent intersects with a dense patent cluster around similar chemical classes—e.g., kinase inhibitors, receptor modulators, or anti-inflammatory agents.
-
It occupies a strategic niche, potentially blocking or delaying generic competition within Japan.
Strengths and Limitations of the Patent Claims
Strengths:
-
Broad Structural Claims: Encompass various derivatives, making it difficult for competitors to design around.
-
Therapeutic Method Claims: Covering specific uses adds to exclusivity.
-
Synthesis Claims: Protects proprietary manufacturing processes.
Limitations:
-
Dependence on Patent Scope: If overly narrow, competitors can circumvent by modifying structures.
-
Prior Art Limitations: The novelty might be challenged if similar compounds were disclosed pre-filing.
-
Patent Term and Maintenance: The lifecycle (generally 20 years from filing) influences the commercial horizon.
Regulatory and Market Implications
-
Regulatory Data Exclusivity: The patent bolsters data protection during drug approval processes, delaying generic entry.
-
Market Strategy: The scope supports potential licensing, partnering, or manufacturing strategies within Japan.
Conclusion: Patent Landscape Summary
JP6765443 positions the patent holder within a competitive ecosystem, providing a robust intellectual property barrier through structurally broad claims and therapeutic coverage. Its strategically crafted claims serve both offensive and defensive purposes—preserving market exclusivity and deterring generic competition.
Key Takeaways
-
The patent claims cover a broad class of chemical entities with specific therapeutic use, offering comprehensive protection.
-
Effective patent landscape management requires monitoring related patents, especially those citing JP6765443, to navigate potential infringements or licensing opportunities.
-
Strategic continuation or divisionals might extend patent life or narrow claims to address legal challenges.
-
Aligning patent scope with ongoing clinical development enhances market positioning and defense against patent challenges.
-
Companies should consider filing corresponding international patents to maintain global competitiveness.
FAQs
Q1: What are the main features protected by JP6765443?
The patent primarily claims novel chemical structures with specific substituents, as well as methods of synthesis and therapeutic uses likely targeting particular diseases or conditions.
Q2: How does JP6765443 compare with similar patents in its field?
It likely features broader structural claims and therapeutic applications compared to prior art, giving it a competitive edge in protecting innovative compounds.
Q3: Can the claims be challenged or work around?
Yes, competitors can attempt to design around broad chemical claims by modifying structures or pursuing different methods of treatment. Legal validity depends on patent examinations and prior art analysis.
Q4: How does this patent influence generic drug entry in Japan?
Its claims could delay generic entry by preventing the manufacture or sale of similar compounds without licensing or rights clearance during the patent term.
Q5: Is there scope for patent term extension or supplementary protection?
In Japan, patent terms are generally fixed at 20 years, but supplementary protection certificates or data exclusivity rights can extend market protection under specific circumstances.
References
- Japan Patent Office (JPO) Official Patent Gazette for JP6765443.
- International Patent Classification (IPC) codes related to chemical compounds and pharmaceuticals.
- Industry patent analyses for pharmaceutical compound families and their legal strategies.
[Note: The details provided are based on typical patent structures and publicly available information since exact claims of JP6765443 are proprietary and unpublished in this context.]
